Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,006,700 | 5,365,300 | 2,756,300 | 1,945,900 | 2,702,300 |
| Marketable Securities | 2,031,000 | 2,099,100 | 957,000 | 1,708,800 | 1,028,700 |
| Receivables | 2,761,700 | 2,553,000 | 2,342,500 | 2,074,200 | 1,695,200 |
| Inventories | 1,878,000 | 2,291,600 | 1,963,000 | 1,495,400 | 1,060,200 |
| Income taxes - deferred | 756,400 | 255,300 | 500,600 | 331,700 | 223,300 |
| TOTAL | $10,795,800 | $12,835,800 | $8,768,900 | $7,804,100 | $6,938,900 |
| Non-Current Assets | |||||
| PPE Net | 7,912,500 | 7,550,900 | 6,539,000 | 5,293,000 | 4,532,400 |
| Investments And Advances | 1,296,600 | 561,400 | 3,374,600 | 3,150,400 | 2,710,900 |
| Other Non-Current Assets | 4,575,900 | 3,918,900 | 3,005,800 | 2,794,500 | 2,251,899 |
| TOTAL | $13,785,000 | $12,031,200 | $12,919,400 | $11,237,900 | $9,495,199 |
| Total Assets | $24,580,800 | $24,867,000 | $21,688,300 | $19,042,000 | $16,434,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 196,500 | 545,400 | 286,300 |
| Accounts payable and accrued liabilities | 781,300 | 648,600 | 875,900 | 676,900 | 624,100 |
| Other current liabilities | 2,878,900 | 2,806,200 | 2,340,300 | 1,703,500 | 1,632,100 |
| TOTAL | $5,716,300 | $7,593,700 | $5,560,800 | $5,063,500 | $5,203,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,763,500 | 4,491,900 | 4,687,800 | 4,358,200 | 3,132,100 |
| Other Non-Current Liabilities | 1,614,000 | 1,241,100 | 1,288,800 | 1,346,700 | 995,000 |
| TOTAL | $8,072,600 | $6,353,400 | $6,362,700 | $5,704,900 | $4,127,100 |
| Total Liabilities | $13,788,900 | $13,947,100 | $11,923,500 | $10,768,400 | $9,330,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,129,983 | 1,132,721 | 1,128,884 | 1,122,676 | 1,124,012 |
| Common Shares | 706,900 | 708,000 | 702,300 | 702,100 | 702,700 |
| Retained earnings | 10,027,200 | 9,724,600 | 9,470,400 | 8,500,100 | 7,411,200 |
| Other shareholders' equity | -3,162,000 | -2,528,100 | -2,913,900 | -3,428,600 | -3,512,900 |
| TOTAL | $10,791,900 | $10,919,900 | $9,764,800 | $8,273,600 | $7,104,000 |
| Total Liabilities And Equity | $24,580,800 | $24,867,000 | $21,688,300 | $19,042,000 | $16,434,100 |